Age-Specific Cytokine Profiling in Children with Mycoplasma Pneumoniae Infections in Post-COVID-19 Era: A

Ying Sun1, Lin Tong1, Ming Lin1

  • 1Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, People's Republic of China.

PubMed
Abstract

Insights

Pediatric Mycoplasma pneumoniae pneumonia (MPP) shows age-specific immune responses, with SARS-CoV-2 IgG indicating distinct immune profiles in younger versus older children. Understanding these patterns is crucial for diagnosing and treating MPP in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Respiratory Medicine

Background:

  • A global resurgence of Mycoplasma pneumoniae pneumonia (MPP) has been observed since mid-2023, following the COVID-19 pandemic.
  • Clinical presentations and immune responses to MPP in pediatric patients exhibit significant age-related variations, complicating diagnosis and treatment.
  • Understanding these age-specific immune dynamics is critical for effective management of pediatric MPP.

Purpose of the Study:

  • To investigate age-specific immune patterns in pediatric patients with Mycoplasma pneumoniae pneumonia (MPP).
  • To analyze the correlation between SARS-CoV-2 antibody levels and cytokine profiles in children with MPP.
  • To elucidate the impact of age and severity on immune responses during MPP.

Main Methods:

  • Retrospective analysis of serum cytokine levels in healthy children and MPP patients.
  • Cytokine profiling of bronchoalveolar lavage fluid (BALF) in severe MPP cases.
  • KEGG pathway analysis for age-related immune patterns and Spearman correlation for SARS-CoV-2 IgG and cytokines.

Main Results:

  • Distinct age-specific cytokine patterns were identified in pediatric MPP patients.
  • In younger children (0-2 years), IL-17, TLR, and TNF pathways were upregulated, while in older children (6-12 years), TLR, RLR, and JAK-STAT pathways were downregulated.
  • SARS-CoV-2 IgG showed differential correlations with specific cytokines across age groups, suggesting varied immune responses.

Conclusions:

  • The immune response in pediatric MPP is age-specific and influenced by disease severity.
  • In younger children, higher SARS-CoV-2 IgG levels correlate with a stronger anti-infective response.
  • In older children, SARS-CoV-2 IgG may be associated with immune exhaustion, highlighting complex age-dependent immune interactions.